Evidence map›Paper›PMID 29599768›Full record

ReviewFrontiers in immunology2018

Mother's Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity.

Kirsty Le Doare, Beth Holder, Aisha Bassett, Pia S Pannaraj

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05992493 (To Explore and Develop the Effective Human Milk Oligosaccharides and Microbiomes on Maternal and Infant Health and Neurodevelopment in Early Infancy), which is not on this map. Cited by 259 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
259citing papers in PubMed, 4 pooled it
34.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05992493 active not recruitingnot on this mapstarted 2023, after this paper: background citation

To Explore and Develop the Effective Human Milk Oligosaccharides and Microbiomes on Maternal and Infant Health and Neurodevelopment in Early Infancy

TypeobservationalSponsorNational Cheng-Kung University HospitalRan2023 to 2026Enrolled300ConditionsInfantile Colic, Breast Feeding, Atopic Dermatitis, Infant Formula
3 · Its place in the literature

Who cites it

259 citing papers in PubMed, 4 syntheses or guidelines pooled it, 470 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Breastfeeding in term and preterm infants with and without growth restriction: A 50-year analysis of incidence and duration.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. Review

199 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Kirsty Le DoareCentre for International Child Health, Imperial College London, London, United Kingdom.
Beth HolderCentre for International Child Health, Imperial College London, London, United Kingdom.
Aisha BassettDivision of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Pia S PannarajDivision of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Children's Hospital of Los Angeles · USImperial College London · GBMRC Unit the Gambia · GM

Funding

Mucosal vs Systemic Influenza Vaccine While Breastfeeding: Milk ImmunityK23HD072774 · NICHD · CHILDREN'S HOSPITAL OF LOS ANGELES · PI PANNARAJ, PIA S · 2013 to 2017
$668k
NICHD NIH HHS K23 HD072774
6 · The paper itself

Abstract

Breast milk is the perfect nutrition for infants, a result of millions of years of evolution. In addition to providing a source of nutrition, breast milk contains a diverse array of microbiota and myriad biologically active components that are thought to guide the infant's developing mucosal immune system. It is believed that bacteria from the mother's intestine may translocate to breast milk and dynamically transfer to the infant. Such interplay between mother and her infant is a key to establishing a healthy infant intestinal microbiome. These intestinal bacteria protect against many respiratory and diarrheal illnesses, but are subject to environmental stresses such as antibiotic use. Orchestrating the development of the microbiota are the human milk oligosaccharides (HMOs), the synthesis of which are partially determined by the maternal genotype. HMOs are thought to play a role in preventing pathogenic bacterial adhesion though multiple mechanisms, while also providing nutrition for the microbiome. Extracellular vesicles (EVs), including exosomes, carry a diverse cargo, including mRNA, miRNA, and cytosolic and membrane-bound proteins, and are readily detectable in human breast milk. Strongly implicated in cell-cell signaling, EVs could therefore may play a further role in the development of the infant microbiome. This review considers the emerging role of breast milk microbiota, bioactive HMOs, and EVs in the establishment of the neonatal microbiome and the consequent potential for modulation of neonatal immune system development.

Indexed as

Immunity, Maternally-AcquiredInfant Nutritional Physiological PhenomenaBreast FeedingGastrointestinal MicrobiomeHumansInfantInfant FormulaMicrobiotaMilk, Humanbreast milkbreast milk microbiomeexosomesextracellular vesicleshuman milk oligosaccharidesinfant microbiomemicrobiomemicrobiota

Identifiers

PMID29599768
PMCPMC5863526
OpenAlexW2791745812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.